The delivery device of SARS-CoV-2 mucosal vaccine matters

被引:0
|
作者
Jian, Fanchong [1 ,2 ,3 ]
Cao, Yunlong [1 ,2 ]
机构
[1] Peking Univ, Biomed Pioneering Innovat Ctr BIOP, Beijing, Peoples R China
[2] Changping Lab, Beijing, Peoples R China
[3] Peking Univ, Coll Chem & Mol Engn, Beijing, Peoples R China
关键词
IMMUNE-RESPONSES;
D O I
10.1038/s41590-024-01950-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mucosal vaccine boosters are expected to enhance protection against SARS-CoV-2 infection. A study now reveals that the delivery device - through either intranasal sprayers or nebulizers - also influences the mucosal immunity and protection efficacy in non-human primates.
引用
收藏
页码:1781 / 1783
页数:3
相关论文
共 50 条
  • [21] An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission
    Li, Weizhong
    Wang, Tao
    Rajendrakumar, Arunraj M.
    Acharya, Gyanada
    Miao, Zizhen
    Varghese, Berin P.
    Yu, Hailiang
    Dhakal, Bibek
    LeRoith, Tanya
    Karunakaran, Athira
    Tuo, Wenbin
    Zhu, Xiaoping
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [22] Improvement of mucosal immunity by a live-attenuated SARS-CoV-2 nasal vaccine
    Yeung, Jason
    Wang, Tian
    Shi, Pei-Yong
    CURRENT OPINION IN VIROLOGY, 2023, 62
  • [23] An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission
    Weizhong Li
    Tao Wang
    Arunraj M. Rajendrakumar
    Gyanada Acharya
    Zizhen Miao
    Berin P. Varghese
    Hailiang Yu
    Bibek Dhakal
    Tanya LeRoith
    Athira Karunakaran
    Wenbin Tuo
    Xiaoping Zhu
    Nature Communications, 14
  • [24] Intranasal Delivery of Thermostable Subunit Vaccine for Cross-Reactive Mucosal and Systemic Antibody Responses Against SARS-CoV-2
    Nguyen, Khue G.
    Mantooth, Siena M.
    Vrabel, Maura R.
    Zaharoff, David A.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [25] Immunogenicity of SARS-CoV-2 Vaccine in Dialysis
    Lacson, Eduardo, Jr.
    Argyropoulos, Christos P.
    Manley, Harold J.
    Aweh, Gideon
    Chin, Andrew I.
    Salman, Loay H.
    Hsu, Caroline M.
    Johnson, Doug S.
    Weiner, Daniel E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (11): : 2735 - 2742
  • [26] Mucosal SARS-CoV-2 Nanoparticle Vaccine Based on Mucosal Adjuvants and Its Immune Effectiveness by Intranasal Administration
    Xiao, Lucheng
    Yu, Weili
    Shen, Lijuan
    Yan, Wenying
    Qi, Jinming
    Hu, Tao
    ACS APPLIED MATERIALS & INTERFACES, 2023, 15 (30) : 35895 - 35905
  • [27] Modular nanoarray vaccine for SARS-CoV-2
    Zagorski, Karen
    Pandey, Kabita
    Rajaiah, Rajesh
    Olwenyi, Omalla A.
    Bade, Aditya N.
    Acharya, Arpan
    Johnston, Morgan
    Filliaux, Shaun
    Lyubchenko, Yuri L.
    Byrareddy, Siddappa N.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2022, 46
  • [28] A protective AAV vaccine for SARS-CoV-2
    Simeng Zhao
    Junzi Ke
    Boyu Yang
    Fangzhi Tan
    Jie Yang
    Chao-Po Lin
    Haopeng Wang
    Guisheng Zhong
    Signal Transduction and Targeted Therapy, 7
  • [29] SARS-CoV-2 incidence and vaccine escape
    Thompson, Robin N.
    Hill, Edward M.
    Gog, Julia R.
    LANCET INFECTIOUS DISEASES, 2021, 21 (07): : 913 - 914
  • [30] A protective AAV vaccine for SARS-CoV-2
    Zhao, Simeng
    Ke, Junzi
    Yang, Boyu
    Tan, Fangzhi
    Yang, Jie
    Lin, Chao-Po
    Wang, Haopeng
    Zhong, Guisheng
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)